Docebo (DCBO) Earnings Analysis
Docebo (DCBO) next reports earnings on 2026-08-07, consensus EPS 0.29 USD. Last quarter (2026-05-08) it beat with EPS 0.34 USD vs 0.33 USD est (+3%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E 16.11.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DCBO next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | 0.29 USD |
| Revenue estimate | 0.07B |
DCBO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | 0.34 USD | 0.33 USD | +3% | Beat |
| 2026-02-27 | 0.45 USD | 0.3463 USD | +29.9% | Beat |
| 2025-11-07 | 0.34 USD | 0.33 USD | +3% | Beat |
| 2025-08-08 | 0.29 USD | 0.2 USD | +45% | Beat |
| 2025-05-09 | 0.27 USD | 0.21 USD | +28.6% | Beat |
| 2025-02-28 | 0.28 USD | 0.33 USD | -15.2% | Miss |
| 2024-11-08 | 0.27 USD | 0.25 USD | +8% | Beat |
Beat rate: 6/7 (86%) over reported quarters with consensus data.
DCBO valuation and analyst view
| Trailing P/E | 16.11 |
|---|---|
| Trailing EPS | 1.226 USD |
| Price / book | -887.64 |
| Dividend yield | 0.00% |
| Market cap | 0.49B |
| Analyst consensus | Buy (8 buy / 2 hold / 0 sell) |
| Avg price target | 32.78 USD |
Related research pages
Frequently asked questions
When is Docebo (DCBO)'s next earnings date?
Docebo is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 0.29 USD and revenue estimate of 0.07B.
Did DCBO beat earnings last quarter?
In its 2026-05-08 report, DCBO posted EPS of 0.34 USD versus a 0.33 USD estimate — a beat of 3%.
What is DCBO's earnings track record?
Over the last 7 reported quarters with consensus data, DCBO beat estimates 6 times (86%).
What is DCBO's current P/E ratio and EPS?
DCBO trades at a trailing P/E of 16.11 on trailing EPS of 1.2259648083736756 USD.
What do analysts rate DCBO?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 32.78 USD.